Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

IVIG - West Nile Encephalitis: Safety and Efficacy

ClinicalTrials.gov ID: NCT00068055

Public ClinicalTrials.gov record NCT00068055. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 12:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin G (OMR-IGG-AM) Containing High Anti-West Nile Virus Antibody Titers in Patients With, or at High Risk for Progression to West Nile Virus (WNV) Encephalitis and/or Myelitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will look at the safety and effectiveness of an experimental medication containing antibodies (Omr-IgG-am™) in people with West Nile Virus (WNV) who already have brain and/or spinal cord inflammation or who are at high risk of developing these problems because they have weak immune systems. WNV can cause problems such as headaches, fever, muscle weakness, coma, and death. Study investigators believe people who are not able to fight infection well may be at risk for developing neurologic problems (having to do with the brain, spinal cord, nerves, and muscles) if they get WNV infection. Up to 110 subjects, 18 years or older, will participate for about 3 months and will receive either Omr-IgG-am™, Polygam® S/D, or placebo given through a small tube placed in a blood vessel in the arm. Hospitalization, up to 5 additional study visits, blood sample collection, MRI pictures of the brain and spinal cord, and neurological, muscle, and heart activity tests are also required.

Study identification

NCT ID
NCT00068055
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Enrollment
62 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2003
Primary completion
Nov 30, 2006
Completion
Nov 30, 2006
Last update posted
Feb 6, 2011

2003 – 2006

United States locations

U.S. sites
66
U.S. states
29
U.S. cities
58
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294-2050
University of South Alabama Medical Center Mobile Alabama 36617
St. Joseph's Hospital and Medical Center Phoenix Arizona 85013
Mayo Clinic Hospital Phoenix Arizona 85054
University of Arizona Health Sciences Center Tucson Arizona 85724
University of Arkansas Little Rock Arkansas 72205
Enloe Medical Center Chico California 95926
Seton Medical Center Daly City California 94015
City of Hope National Medical Center Duarte California 91010
Kaiser Permanente South Bay Medical Center Harbor City California 90710
University of Southern California Los Angeles California 90033
University of California Irvine Orange California 92868-3298
University of California Davis Medical Center Sacramento California 95817
University of California San Francisco San Francisco California 94114
California Pacific Medical Center San Francisco California 94115
Santa Rosa Kaiser Medical Santa Rosa California 95403
Exempla St. Joseph Hospital Denver Colorado 80218
University of Colorado Denver Colorado 80262
George Washington University Medical Center Washington D.C. District of Columbia 20037
Idaho Falls Infectious Diseases, PLLC Idaho Falls Idaho 83404
Loyola University Maywood Illinois 60153
Indiana University Indianapolis Indiana 46202-5124
University of Kansas Medical Center Kansas City Kansas 66160
Via Christi Regional Medical Center Wichita Kansas 67214
University of Kentucky Lexington Kentucky 40536-0084
Tulane University New Orleans Louisiana 70112
Johns Hopkins University Baltimore Maryland 21287
National Institutes of Health Bethesda Maryland 20892-1662
University of Michigan Ann Arbor Michigan 48105
Wayne State University Detroit Michigan 48201
Washington University in St. Louis St Louis Missouri 63110-1093
Saint Louis University St Louis Missouri 63110
Mercury Street Medical Group Butte Montana 59701
Infectious Disease Specialists, PC Missoula Montana 59802
Central Nebraska Medical Clinic Broken Bow Nebraska 68822
McCook Clinic, PC McCook Nebraska 69001
Great Plains Regional Medical Center North Platte Nebraska 69101
VA Medical Center - Omaha Omaha Nebraska 68105
Creighton University Omaha Nebraska 68131
University of Nebraska Medical Center Omaha Nebraska 68198-7630
Clara Maass Medical Center Belleville New Jersey 07109
University of New Mexico Albuquerque New Mexico 87106
Flushing Hospital Medical Center Flushing New York 11355
St. Alexius Medical Center Bismarck North Dakota 58506
Dakota Clinic at Innovis Fargo North Dakota 58103
MeritCare Hospital Fargo North Dakota 58122
Trinity Health - Hospital Minot North Dakota 58701
University Hospital Cincinnati Ohio 45219
University Hospitals of Cleveland Cleveland Ohio 44106
University of Toledo Toledo Ohio 43614
Wright-Patterson Medical Center Wright-Patterson AFB Ohio 45433
Legacy Good Samaritan Portland Oregon 97210
Lehigh Valley Hospital Allentown Pennsylvania 18103
The Reading Hospital and Medical Center West Reading Pennsylvania 19611
Memorial Hospital of RI Pawtucket Rhode Island 02860
Rhode Island Hospital Providence Rhode Island 02903
Infectious Disease Consultations - Rapid City Rapid City South Dakota 57701
Avera Research Institute Sioux Falls South Dakota 57105
Vanderbilt University Nashville Tennessee 37205
The University of Texas Southwestern Medical Center Dallas Texas 75390-8884
The University of Texas Medical Branch Galveston Texas 77555-0167
The University of Texas Health Science Center at Houston Houston Texas 77030
The University of Texas Health Science Center San Antonio Texas 78229-3900
Wilford Hall Medical Center San Antonio Texas 78236
The University of Texas Health Science Center at Tyler Tyler Texas 75708
University of Virginia Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00068055, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 6, 2011 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00068055 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →